🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
Last 30 Days
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — Last 30 Days
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(2118)
All (2118)
Buys (184)
Sells (1934)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Atara Biotherapeutics, Inc.
(ATRA)
Grant-Huerta Yanina
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
100
Price
$5.08
Total Value
$508.30
Shares Held After
31,750
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Grant-Huerta Yanina
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
377
Price
$5.08
Total Value
$1.92K
Shares Held After
31,850
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Grant-Huerta Yanina
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
1,603
Price
$5.08
Total Value
$8.14K
Shares Held After
32,227
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Grant-Huerta Yanina
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
24
Price
$5.08
Total Value
$121.85
Shares Held After
33,830
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Gemini Therapeutics, Inc.
(GMTX)
Savage William Jacob
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
2,986
Price
$66.41
Total Value
$198.30K
Shares Held After
85,211
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Gemini Therapeutics, Inc.
(GMTX)
Savage William Jacob
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
4,392
Price
$65.52
Total Value
$287.77K
Shares Held After
88,197
% of Holdings
4.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Pulmonx Corp
(LUNG)
French Glendon E. III
— Director
Mar 2, 2026
Sale
Shares
58,368
Price
$1.43
Total Value
$83.47K
Shares Held After
1,409,511
% of Holdings
4.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Pulmonx Corp
(LUNG)
French Glendon E. III
— Director
Mar 2, 2026
Sale
Shares
6,737
Price
$1.43
Total Value
$9.63K
Shares Held After
1,467,879
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Pulmonx Corp
(LUNG)
French Glendon E. III
— Director
Mar 2, 2026
Sale
Shares
2,708
Price
$1.43
Total Value
$3.87K
Shares Held After
1,474,616
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
Kapusta Matthew C
— Director
Mar 2, 2026
Sale
Shares
34,437
Price
$9.95
Total Value
$342.65K
Shares Held After
604,639
% of Holdings
5.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oscar Health, Inc.
(OSCR)
Baltrus Victoria
— Chief Accounting Officer
Mar 2, 2026
Sale
Shares
4,638
Price
$13.39
Total Value
$62.10K
Shares Held After
216,112
% of Holdings
2.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Tempus AI, Inc.
(TEM)
Epstein David R
— Director
Mar 2, 2026
Sale
Shares
250
Price
$50.69
Total Value
$12.67K
Shares Held After
25,801
% of Holdings
1.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oscar Health, Inc.
(OSCR)
Liang Janet
— President, Oscar Insurance
Mar 2, 2026
Sale
Shares
7,453
Price
$13.39
Total Value
$99.80K
Shares Held After
271,532
% of Holdings
2.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Monte Rosa Therapeutics, Inc.
(GLUE)
Warmuth Markus
— Director
Mar 2, 2026
Sale
Shares
5,466
Price
$17.92
Total Value
$97.97K
Shares Held After
613,471
% of Holdings
0.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ProMIS Neurosciences Inc.
(PMN)
Williams Eugene
— Director
Mar 2, 2026
Purchase
Shares
1,000
Price
$22.53
Total Value
$22.53K
Shares Held After
7,397
% of Holdings
13.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xeris Biopharma Holdings, Inc.
(XERS)
Hecht Beth
— Chief Legal Officer and Corporate Secretary
Mar 2, 2026
Sale
Shares
100
Price
$7.06
Total Value
$706.00
Shares Held After
1,226,507
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xeris Biopharma Holdings, Inc.
(XERS)
Hecht Beth
— Chief Legal Officer and Corporate Secretary
Mar 2, 2026
Sale
Shares
16,567
Price
$6.24
Total Value
$103.38K
Shares Held After
1,226,607
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oscar Health, Inc.
(OSCR)
Blackley Richard Scott
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
19,221
Price
$13.39
Total Value
$257.37K
Shares Held After
1,466,660
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
Abi-Saab Walid
— Chief Medical Officer
Mar 2, 2026
Sale
Shares
1,660
Price
$9.95
Total Value
$16.52K
Shares Held After
148,777
% of Holdings
1.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
908 Devices Inc.
(MASS)
McCallion Kevin J.
— SVP, Products and Production
Mar 2, 2026
Sale
Shares
7
Price
$7.00
Total Value
$49.00
Shares Held After
44,918
% of Holdings
0.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
10x Genomics, Inc.
(TXG)
Saxonov Serge
— Director
Mar 2, 2026
Sale
Shares
1,860
Price
$23.18
Total Value
$43.11K
Shares Held After
1,203,667
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
10x Genomics, Inc.
(TXG)
Saxonov Serge
— Director
Mar 2, 2026
Sale
Shares
14,292
Price
$22.67
Total Value
$323.99K
Shares Held After
1,205,527
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Stoke Therapeutics, Inc.
(STOK)
Krainer Adrian R.
— Director
Mar 2, 2026
Sale
Shares
7,229
Price
$39.66
Total Value
$286.72K
Shares Held After
316,545
% of Holdings
2.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Oscar Health, Inc.
(OSCR)
Schlosser Mario
— Director
Mar 2, 2026
Sale
Shares
24,335
Price
$13.39
Total Value
$325.85K
Shares Held After
514,986
% of Holdings
4.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
KOZARICH JOHN W
— Director
Mar 2, 2026
Sale
Shares
42
Price
$203.57
Total Value
$8.55K
Shares Held After
42,720
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
KOZARICH JOHN W
— Director
Mar 2, 2026
Sale
Shares
50
Price
$202.54
Total Value
$10.13K
Shares Held After
42,762
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
KOZARICH JOHN W
— Director
Mar 2, 2026
Sale
Shares
83
Price
$201.65
Total Value
$16.74K
Shares Held After
42,812
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
KOZARICH JOHN W
— Director
Mar 2, 2026
Sale
Shares
41
Price
$200.40
Total Value
$8.22K
Shares Held After
42,895
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
KOZARICH JOHN W
— Director
Mar 2, 2026
Sale
Shares
204
Price
$199.69
Total Value
$40.74K
Shares Held After
42,936
% of Holdings
0.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LIGAND PHARMACEUTICALS INC
(LGND)
KOZARICH JOHN W
— Director
Mar 2, 2026
Sale
Shares
47
Price
$197.14
Total Value
$9.27K
Shares Held After
43,140
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LifeStance Health Group, Inc.
(LFST)
BLACK DARREN M.
— Director
Mar 2, 2026
Sale
Shares
4,314,939
Price
$7.01
Total Value
$30.25M
Shares Held After
29,209,776
% of Holdings
12.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
uniQure N.V.
(QURE)
KLEMT CHRISTIAN
— Chief Financial Officer
Mar 2, 2026
Sale
Shares
12,532
Price
$9.95
Total Value
$124.69K
Shares Held After
198,981
% of Holdings
5.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
FibroBiologics, Inc.
(FBLG)
O'HEERON PETE
— Director
Mar 2, 2026
Purchase
Shares
17,428
Price
$0.35
Total Value
$6.15K
Shares Held After
5,924,075
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Arcutis Biotherapeutics, Inc.
(ARQT)
Leonard Keith R
— Director
Mar 2, 2026
Sale
Shares
39,272
Price
$25.39
Total Value
$997.19K
Shares Held After
22,123
% of Holdings
64.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Nguyen AnhCo
— Director
Mar 2, 2026
Sale
Shares
1,442
Price
$5.09
Total Value
$7.34K
Shares Held After
61,978
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Nguyen AnhCo
— Director
Mar 2, 2026
Sale
Shares
1,298
Price
$5.09
Total Value
$6.60K
Shares Held After
63,420
% of Holdings
2.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Nguyen AnhCo
— Director
Mar 2, 2026
Sale
Shares
58
Price
$5.08
Total Value
$294.64
Shares Held After
64,718
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Atara Biotherapeutics, Inc.
(ATRA)
Nguyen AnhCo
— Director
Mar 2, 2026
Sale
Shares
198
Price
$5.08
Total Value
$1.01K
Shares Held After
64,776
% of Holdings
0.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERTEX PHARMACEUTICALS INC / MA
(VRTX)
Liu Joy
— EVP and Chief Legal Officer
Mar 2, 2026
Sale
Shares
892
Price
$495.96
Total Value
$442.40K
Shares Held After
22,811
% of Holdings
3.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
LifeStance Health Group, Inc.
(LFST)
TPG GP A, LLC
— 10% Owner
Mar 2, 2026
Sale
Shares
20,685,061
Price
$7.01
Total Value
$145.00M
Shares Held After
140,026,557
% of Holdings
12.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
VERACYTE, INC.
(VCYT)
Febbo Phillip G.
— Chief Scientific & Med Officer
Mar 2, 2026
Sale
Shares
13,425
Price
$36.16
Total Value
$485.43K
Shares Held After
117,346
% of Holdings
10.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ANI PHARMACEUTICALS INC
(ANIP)
Mutz Christopher
— HEAD OF RARE DISEASE
Mar 2, 2026
Sale
Shares
417
Price
$74.00
Total Value
$30.86K
Shares Held After
103,508
% of Holdings
0.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Arcutis Biotherapeutics, Inc.
(ARQT)
Welgus Howard G.
— Director
Mar 2, 2026
Sale
Shares
10,000
Price
$25.65
Total Value
$256.52K
Shares Held After
49,744
% of Holdings
16.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Hopkinson Craig C.
— EVP R&D, Chief Medical Officer
Mar 2, 2026
Sale
Shares
9,000
Price
$29.72
Total Value
$267.49K
Shares Held After
89,389
% of Holdings
9.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Allogene Therapeutics, Inc.
(ALLO)
Beneski Benjamin Machinas
— SVP, Chief Technical Officer
Mar 2, 2026
Sale
Shares
7,132
Price
$2.60
Total Value
$18.54K
Shares Held After
203,040
% of Holdings
3.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Gaffin David Joseph
— EVP, CLO, Alkermes, Inc.
Mar 2, 2026
Sale
Shares
2,034
Price
$29.29
Total Value
$59.58K
Shares Held After
237,660
% of Holdings
0.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vericel Corp
(VCEL)
Halpin Michael
— Chief Operating Officer
Mar 2, 2026
Sale
Shares
10,305
Price
$35.30
Total Value
$363.77K
Shares Held After
16,080
% of Holdings
39.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
QUEST DIAGNOSTICS INC
(DGX)
Davis J. E.
— Director
Mar 2, 2026
Sale
Shares
10,000
Price
$212.52
Total Value
$2.13M
Shares Held After
117,185
% of Holdings
7.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kiniksa Pharmaceuticals International, plc
(KNSA)
Paolini John F.
— CHIEF MEDICAL OFFICER
Mar 2, 2026
Sale
Shares
5,714
Price
$45.92
Total Value
$262.39K
Shares Held After
61,324
% of Holdings
8.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Kiniksa Pharmaceuticals International, plc
(KNSA)
Paolini John F.
— CHIEF MEDICAL OFFICER
Mar 2, 2026
Sale
Shares
22,223
Price
$44.88
Total Value
$997.37K
Shares Held After
67,038
% of Holdings
24.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Next →
Showing 1601–1650 of 2118 transactions (page 33 of 43)
Version: v26.3.33